1.02776
D-(+)- Trealosa dihydrate
EMPROVE® EXPERT, Ph. Eur., ChP, NF, JP
Fabricación farmacéutica
Sinónimos:
α,α-Trealosa, α-D-Glucopiranosil-α-D-glucopiranósido
About This Item
Productos recomendados
agency
ChP
JP
NF
Ph. Eur.
Quality Level
product line
EMPROVE® EXPERT
form
solid
feature
RNase and DNase free
mp
96.5-97.5 °C
application(s)
liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical
semi-solid formulation
storage temp.
no temp limit
SMILES string
[H]O[H].[H]O[H].OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
InChI
1S/C12H22O11.2H2O/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12;;/h3-20H,1-2H2;2*1H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-;;/m1../s1
InChI key
DPVHGFAJLZWDOC-PVXXTIHASA-N
¿Está buscando productos similares? Visita Guía de comparación de productos
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Trehalose dihydrate Emprove® Expert is low in endotoxins and bioburden, making it the right choice for your high-risk applications.
Legal Information
Application
also commonly purchased with this product
Storage Class
11 - Combustible Solids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Artículos
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.
Contenido relacionado
Learn more on mAb subcutaneous or intravenous formulation, and the relevant associated products, including excipients.
Learn more on mAb subcutaneous or intravenous formulation, and the relevant associated products, including excipients.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico